GGrantIndex
← Leaderboards

Joel F Habener

Massachusetts General Hospital

$8,701,115
Attributed
$8,701,115
Total exposure
8
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $437.6K · FY200519
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$11,725,236 · 9

By mechanism

P30$4,049,825 · 3
R01$3,575,540 · 3
U19$3,024,121 · 1
U54$729,750 · 1
R21$346,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusHormone Regulation /Control MechanismLaboratory MouseHormone ReceptorPancreatic IsletsGenetically Modified AnimalsEndocrinologyIncretin HormoneApoptosisStem CellsProtein Structure FunctionBaseCareerGrantResearch ProposalsFundingAreaRecording Of Previous EventsInnovationBostonFoundationsInvestigationProgramsResearch Personnel

Grant awards (36)

Pilot and Feasibility Program$386,579
P30 · FY2019 · DK · contact PI
Pilot and Feasibility Program$386,579
P30 · FY2018 · DK · contact PI
Pilot and Feasibility Program$386,577
P30 · FY2017 · DK · contact PI
Pilot and Feasibility Program$386,579
P30 · FY2016 · DK · contact PI
Pilot and Feasibility Program$386,579
P30 · FY2015 · DK · contact PI
Pilot & Feasibility Program$423,319
P30 · FY2014 · DK · contact PI
Pilot & Feasibility Program$409,365
P30 · FY2013 · DK · contact PI
Pilot & Feasibility Program$423,319
P30 · FY2012 · DK · contact PI
Pilot & Feasibility Program$423,319
P30 · FY2011 · DK · contact PI
Pilot & Feasibility Program$437,610
P30 · FY2010 · DK · contact PI
Glucagon Biosynthesis and Metabolism$289,335
R01 · FY2008 · DK · contact PI
Glucagon Biosynthesis and Metabolism$295,240
R01 · FY2007 · DK · contact PI
Glucagon Biosynthesis and Metabolism$304,058
R01 · FY2006 · DK · contact PI
Glucagon Biosynthesis and Metabolism$311,375
R01 · FY2005 · DK
Program Project,Restoration of Endocrine Pancreas Funct*$750,000
U19 · FY2004 · DK
Program Project,Restoration of Endocrine Pancreas Funct*$750,408
U19 · FY2003 · DK
TRANSCRIPTION FACTORS AND THE ENDOCRINE PANCREAS$273,720
R01 · FY2003 · DK
Program Project,Restoration of Endocrine Pancreas Funct*$729,922
U19 · FY2002 · DK
TRANSCRIPTION FACTORS AND THE ENDOCRINE PANCREAS$265,747
R01 · FY2002 · DK
NEUROENDOCRINE CONTROL OF SPERMATOGENESIS$243,250
U54 · FY2002 · HD
GLUCAGON BIOSYNTHESIS AND METABOLISM$234,048
R01 · FY2002 · DK
GLYCOPROTEIN HORMONE BIOSYNTHESIS AND ACTION$218,270
R01 · FY2002 · DK
PANCREATIC ISLET-DERIVED STEM CELLS$173,000
R21 · FY2002 · DK
PILOT AND FEASIBILITY (P/F) PROGRAM$0
P30 · FY2002 · DK
Restoration of Endocrine Pancreas Function$793,791
U19 · FY2001 · DK
TRANSCRIPTION FACTORS AND THE ENDOCRINE PANCREAS$258,007
R01 · FY2001 · DK
NEUROENDOCRINE CONTROL OF SPERMATOGENESIS$243,250
U54 · FY2001 · HD
GLUCAGON BIOSYNTHESIS AND METABOLISM$227,230
R01 · FY2001 · DK
GLYCOPROTEIN HORMONE BIOSYNTHESIS AND ACTION$212,010
R01 · FY2001 · DK
PANCREATIC ISLET-DERIVED STEM CELLS$173,000
R21 · FY2001 · DK
PILOT AND FEASIBILITY (P/F) PROGRAM$0
P30 · FY2001 · DK
PILOT AND FEASIBILITY (P/F) PROGRAM$0
P30 · FY2001 · DK
TRANSCRIPTION FACTORS AND THE ENDOCRINE PANCREAS$250,490
R01 · FY2000 · DK
NEUROENDOCRINE CONTROL OF SPERMATOGENESIS$243,250
U54 · FY2000 · HD
GLUCAGON BIOSYNTHESIS AND METABOLISM$220,611
R01 · FY2000 · DK
GLYCOPROTEIN HORMONE BIOSYNTHESIS AND ACTION$215,399
R01 · FY2000 · DK